Roher Alex E, Debbins Josef P, Malek-Ahmadi Michael, Chen Kewei, Pipe James G, Maze Sharmeen, Belden Christine, Maarouf Chera L, Thiyyagura Pradeep, Mo Hua, Hunter Jesse M, Kokjohn Tyler A, Walker Douglas G, Kruchowsky Jane C, Belohlavek Marek, Sabbagh Marwan N, Beach Thomas G
The Longtine Center for Neurodegenerative Biochemistry, Banner Sun Health Research Institute, Sun City, AZ 85351, USA.
Vasc Health Risk Manag. 2012;8:599-611. doi: 10.2147/VHRM.S34874. Epub 2012 Oct 23.
Alzheimer's disease (AD) dementia is a consequence of heterogeneous and complex interactions of age-related neurodegeneration and vascular-associated pathologies. Evidence has accumulated that there is increased atherosclerosis/arteriosclerosis of the intracranial arteries in AD and that this may be additive or synergistic with respect to the generation of hypoxia/ischemia and cognitive dysfunction. The effectiveness of pharmacologic therapies and lifestyle modification in reducing cardiovascular disease has prompted a reconsideration of the roles that cardiovascular disease and cerebrovascular function play in the pathogenesis of dementia.
Using two-dimensional phase-contrast magnetic resonance imaging, we quantified cerebral blood flow within the internal carotid, basilar, and middle cerebral arteries in a group of individuals with mild to moderate AD (n = 8) and compared the results with those from a group of age-matched nondemented control (NDC) subjects (n = 9). Clinical and psychometric testing was performed on all individuals, as well as obtaining their magnetic resonance imaging-based hippocampal volumes.
Our experiments reveal that total cerebral blood flow was 20% lower in the AD group than in the NDC group, and that these values were directly correlated with pulse pressure and cognitive measures. The AD group had a significantly lower pulse pressure (mean AD 48, mean NDC 71; P = 0.0004). A significant group difference was also observed in their hippocampal volumes. Composite z-scores for clinical, psychometric, hippocampal volume, and hemodynamic data differed between the AD and NDC subjects, with values in the former being significantly lower (t = 12.00, df = 1, P = 0.001) than in the latter.
These results indicate an association between brain hypoperfusion and the dementia of AD. Cardiovascular disease combined with brain hypoperfusion may participate in the pathogenesis/pathophysiology of neurodegenerative diseases. Future longitudinal and larger-scale confirmatory investigations measuring multidomain parameters are warranted.
阿尔茨海默病(AD)性痴呆是与年龄相关的神经退行性变和血管相关病理的异质性和复杂相互作用的结果。已有证据表明,AD患者颅内动脉的动脉粥样硬化/动脉硬化增加,并且这在缺氧/缺血和认知功能障碍的发生方面可能具有累加或协同作用。药物治疗和生活方式改变在降低心血管疾病方面的有效性促使人们重新思考心血管疾病和脑血管功能在痴呆发病机制中的作用。
我们使用二维相位对比磁共振成像,对一组轻度至中度AD患者(n = 8)的颈内动脉、基底动脉和大脑中动脉内的脑血流量进行了量化,并将结果与一组年龄匹配的非痴呆对照(NDC)受试者(n = 9)的结果进行了比较。对所有个体进行了临床和心理测量测试,并获取了基于磁共振成像的海马体积。
我们的实验表明,AD组的总脑血流量比NDC组低20%,并且这些值与脉压和认知指标直接相关。AD组的脉压显著更低(AD组平均为48,NDC组平均为71;P = 0.0004)。在他们的海马体积方面也观察到了显著的组间差异。AD组和NDC组在临床、心理测量、海马体积和血流动力学数据的综合z评分有所不同,前者的值显著低于后者(t = 12.00,自由度 = 1,P = 0.001)。
这些结果表明脑灌注不足与AD性痴呆之间存在关联。心血管疾病与脑灌注不足可能参与神经退行性疾病的发病机制/病理生理学。未来有必要进行测量多领域参数的纵向和更大规模的验证性研究。